We are live on ! Find out more
AC

Athanor Capital Portfolio holdings

AUM $24.6M
1-Year Est. Return 2.49%
This Fund
S&P 500
This Quarter Est. Return
+22.04%
1 Year Est. Return
+2.49%
3 Year Est. Return
+171.12%
5 Year Est. Return
+304.82%
10 Year Est. Return
AUM
$4.4B
AUM Growth
+$1.77B
Cap. Flow
+$1.51B
Cap. Flow %
34.38%
Top 10 Hldgs %
34.96%
Holding
878
New
355
Increased
146
Reduced
175
Closed
189

Sector Composition

Rank Sector Weight
1 Technology 11.27%
2 Consumer Discretionary 10.7%
3 Communication Services 7.02%
4 Financials 6.19%
5 Industrials 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTGT icon
426
TechTarget
TTGT
$325M
$554K 0.01%
9,364
-15,472
-62% -$799K
CHRS icon
427
Coherus Oncology
CHRS
$217M
$553K 0.01%
31,800
-3,210
-9% -$57.2K
BHVN
428
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$550K 0.01%
+6,420
New +$544K
PHAT icon
429
Phathom Pharmaceuticals
PHAT
$708M
$547K 0.01%
16,472
-68
-0.4% -$2.75K
AMT icon
430
American Tower
AMT
$80.8B
$545K 0.01%
+2,429
New +$565K
VRTU
431
DELISTED
Virtusa Corporation
VRTU
$543K 0.01%
+10,618
New +$533K
AXTA icon
432
Axalta
AXTA
$7.66B
$540K 0.01%
+18,916
New +$515K
FWONA icon
433
Liberty Media Series A
FWONA
$22.5B
$538K 0.01%
14,803
+2,667
+22% +$93.2K
VYGG.U
434
DELISTED
Vy Global Growth Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant to acquire one Class A Ordinary Share
VYGG.U
$538K 0.01%
+50,000
New +$527K
NOV icon
435
NOV
NOV
$6.93B
$536K 0.01%
39,048
-52,885
-58% -$598K
MC icon
436
Moelis & Co
MC
$4.97B
$535K 0.01%
11,443
-4,673
-29% -$188K
CYTK icon
437
Cytokinetics
CYTK
$10.5B
$533K 0.01%
+25,649
New +$469K
KROS icon
438
Keros Therapeutics
KROS
$199M
$532K 0.01%
+7,547
New +$476K
KURA icon
439
Kura Oncology
KURA
$800M
$532K 0.01%
16,289
-4,129
-20% -$145K
LH icon
440
Labcorp
LH
$25B
$528K 0.01%
+3,021
New +$522K
IVZ icon
441
Invesco
IVZ
$13.1B
$526K 0.01%
+30,155
New +$464K
ADAP
442
DELISTED
Adaptimmune Therapeutics
ADAP
$524K 0.01%
97,240
+34,492
+55% +$187K
RYTM icon
443
Rhythm Pharmaceuticals
RYTM
$6.81B
$524K 0.01%
17,631
+5,211
+42% +$132K
RVTY icon
444
Revvity
RVTY
$12.6B
$519K 0.01%
+3,615
New +$481K
CBOE icon
445
Cboe Global Markets
CBOE
$32.5B
$517K 0.01%
+5,554
New +$486K
BBBY
446
Bed Bath & Beyond
BBBY
$481M
$514K 0.01%
11,790
-2,624
-18% -$155K
POWI icon
447
Power Integrations
POWI
$3.38B
$512K 0.01%
6,249
-10,701
-63% -$726K
BBWI icon
448
Bath & Body Works
BBWI
$4.06B
$510K 0.01%
16,967
-219,342
-93% -$6.37M
ABG icon
449
Asbury Automotive
ABG
$4.31B
$505K 0.01%
3,462
-6,407
-65% -$794K
DNOW icon
450
DNOW Inc
DNOW
$2.58B
$504K 0.01%
70,197

Similar funds

Athanor Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Athanor Capital held 878 positions worth $4.4B, up 67% from $2.63B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Athanor Capital deployed $1.51B of net new capital in Q4 2020, opening 355 new positions and adding to 146 existing holdings. Its largest new stake was Slack Technologies, Inc.: 1,176,092 shares worth $49.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Verizon, an estimated $39.5M trimmed.

  • Athanor Capital's largest Q4 2020 buy was Slack Technologies, Inc.: 1,176,092 shares worth $49.7M.
  • Athanor Capital added most to iShares Russell 2000 ETF in Q4 2020, an estimated $92.6M increase.
  • Athanor Capital's biggest Q4 2020 reduction was Verizon, cutting an estimated $39.5M.
  • Athanor Capital fully exited Noble Energy, Inc. in Q4 2020, selling an estimated $33.6M.
  • Athanor Capital's ten largest holdings make up 35% of its $4.4B portfolio in Q4 2020.
  • Athanor Capital opened 355 new positions and closed 189 in Q4 2020.
  • Athanor Capital's portfolio value rose 67% quarter-over-quarter to $4.4B.

Based on Athanor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.